Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results
11/14/2013 10:50:52 AM
NEW YORK, Nov. 14, 2013 /PRNewswire/ -- Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases such as primary biliary cirrhosis, today reported financial results for the three and nine months ended September 30, 2013 and announced presentations at upcoming investor conferences.
Help employers find you! Check out all the jobs and post your resume.